⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CORT News
Corcept Therapeutics Inc.
ROSEN, A LEADING NATIONAL FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action – CORT
globenewswire.com
CORT
Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
Corcept Therapeutics Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com
CORT
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
globenewswire.com
CORT
Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline
globenewswire.com
CORT
CORT LAWSUIT ALERT: Levi & Korsinsky Notifies Corcept Therapeutics Incorporated Investors of a Class Action Lawsuit and Upcoming Deadline
prnewswire.com
CORT
Pomerantz LLP Alerts Shareholders to Investor Suit Against Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
CORT
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
globenewswire.com
CORT
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
prnewswire.com
CORT